View full metadata

THIS DOI METADATA WAS LAST UPDATED: 2024-01-10 22:57

DOI data

10.3280/RSF2016-002007

Serial Article

Cite as

Journal Data
Journal Issue Data
Serial Article Data
Reference list of 10.3280/RSF2016-002007

Unstructured Citation

[1] Lovaste R, Colasante E, Pitino A, Gori M. Valutazione dell’efficacia dei trattamenti metadonici effettuati nei SerD della Provincia Autonoma di Trento. Mission 2010; 29:53-9.

Unstructured Citation

[2] Silins E, Sannibale C, Larney S, Wodak A, Mattick R. Residential detoxification: essential for marginalised, severely alcohol- and drug-dependent individuals. Drug Alcohol Rev 2008; 27:414-9.

https://doi.org/10.1080/09595230701750650

Unstructured Citation

[3] Smyth BP, Barry J, Keenan E, Ducray K. Lapse and relapse following inpatient treatment of opiate dependence. Ir Med J 2010; 103:176-9. [4] Amodeo M, Lundgren L, Chassler D, Witas J. High-frequency users of detoxification: who are they? Subst Use Misuse 2008; 43:839-49.

Unstructured Citation

[5] Lugoboni F, Quaglio GL, Faccini M, Pajusco B, Casari R, Albero A, Mezzelani P. Un’Unità di degenza interamente dedicata alla dipendenza da sostanze: i primi 10 anni di attività di Medicina delle Dipendenze del Policlinico di Verona. Mission 2010; 31:9-15.

Unstructured Citation

[6] Maremmani I, Cibin M, Pani PP, Rossi A, Turchetti G. Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder. Int J Environ Res Public Health 2015; 12 (11): 14828-41.

https://doi.org/10.3390/ijerph121114828

Unstructured Citation

[7] Soares Pinto SP, Zambon A, Cibin M, et al. Poliabuso e doppia diagnosi nelle residenzialità alcologiche ospedaliere: caratteristiche dei pazienti e dei percorsi terapeutici/riabilitativi. Mission 2013; 37: 19-28.

Unstructured Citation

[8] Chiamulera C. Cue reactivity in nicotine and tobacco dependence: a “multipleaction” model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli. Brain Res Brain Res Rev. 2005; 48(1):74-97.

https://doi.org/10.1016/j.brainresrev.2004.08.005

Unstructured Citation

[9] Kalivas PW, O’Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008; 33(1):166-80.

https://doi.org/10.1038/sj.npp.1301564

Unstructured Citation

[10] Sandrini M, Cohen LG, Censor N. Modulating reconsolidation: a link to causal systems-level dynamics of human memories. Trends Cogn Sci. 2015; 19(8): 475-82.

https://doi.org/10.1016/j.tics.2015.06.002

Unstructured Citation

[11] Casartelli L, Chiamulera C. The motor way: Clinical implications of understanding and shaping actions with the motor system in autism and drug addiction. Cogn Affect Behav Neurosci. 2016; 16(2):191-206.

https://doi.org/10.3758/s13415-015-0399-7

Unstructured Citation

[12] Chiamulera C, Cibin M. Drinking reduction and reversibility of neuroadaptation in alcoholism. J Psychopharmacol. 2014; 28(8):810-2.

https://doi.org/10.1177/0269881114538544

Unstructured Citation

[13] Piazza PV, Deroche-Gamonet V. A multistep general theory of transition to addiction. Psychopharmacology 2013; 229(3):387-413.

https://doi.org/10.1007/s00213-013-3224-4

Unstructured Citation

[14] Chiamulera C, Hinnenthal I, Auber A, Cibin M. Reconsolidation of maladaptive memories as a therapeutic target: pre-clinical data and clinical approaches. Front Psychiatry 2014; 5:107.

https://doi.org/10.3389/fpsyt.2014.00107

Unstructured Citation

[15] Kim J, Song B, Hong I, Kim J, Lee J, Park S, Eom JY, Lee CJ, Lee S, Choi S. Reactivation of fear memory renders consolidated amygdala synapses labile. J Neurosci. 2010; 30(28): 9631-40.

https://doi.org/10.1523/JNEUROSCI.0940-10.2010

Unstructured Citation

[16] Monfils MH, Cowansage KK, Klann E, LeDoux JE. Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science 2009; 324 (5929): 951-5.

https://doi.org/10.1126/science.1167975

Unstructured Citation

[17] Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 2010; 463 (7277): 49-53.

https://doi.org/10.1038/nature08637

Unstructured Citation

[18] Nader K, Schafe GE, Le Doux JE. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 2000; 406 (6797): 722-6.

https://doi.org/10.1038/35021052

Unstructured Citation

[19] Nader K. Memory traces unbound. Trends Neurosci. 2003; 26(2): 65-72. [20] Torregrossa MM, Taylor JR. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction. Psychopharmacology 2013; 226(4):659-72.

Unstructured Citation

[21] Auber A, Tedesco V, Jones CE, Monfils MH, Chiamulera C. Post-retrieval extinction as reconsolidation interference: methodological issues or boundary conditions? Psychopharmacology 2013; 226(4): 631-47.

https://doi.org/10.1007/s00213-013-3004-1

Unstructured Citation

[22] Agren T. Human reconsolidation: a reactivation and update. Brain Res Bull. 2014; 105:70-82.

https://doi.org/10.1016/j.brainresbull.2013.12.010

Unstructured Citation

[23] Cai WH, Blundell J, Han J, Greene RW, Powell CM. Postreactivation glucocorticoids impair recall of established fear memory. J Neurosci. 2006; 26(37): 9560-6.

https://doi.org/10.1523/JNEUROSCI.2397-06.2006

Unstructured Citation

[25] Rodriguez WA, Rodriguez SB, Phillips MY, Martinez JL Jr. Post-reactivation cocaine administration facilitates later acquisition of an avoidance response in rats. Behav Brain Res. 1993; 59(1-2):125-9.

https://doi.org/10.1016/0166-4328(93)90158-M

Unstructured Citation

[26] Logan DE, Marlatt GA. Harm reduction therapy: a practice-friendly review of research. J Clin Psychol. 2010; 66(2):201-14.

https://doi.org/10.1002/jclp.20669

Unstructured Citation

[27] Sinclair JD Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol and Alcoholism 2001; 36(1): 2-10.

https://doi.org/10.1093/alcalc/36.1.2

Unstructured Citation

[28] Fantozzi F, Sinclair D. La ricaduta nell’alcol: un concetto vincente, ma … in via di estinzione? Personalità/Dipendenze 2004; 10: 219-243.

Unstructured Citation

[29] Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group, A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, asneeded use, in patients with alcohol dependence. Eur Neuropsychopharmacol. 2013; 23(11):1432-42.

https://doi.org/10.1016/j.euroneuro.2013.02.006

Unstructured Citation

[30] Van den Brink W, Sørensen P, Torup L, Mann K, Gual A, for the SENSE Study Group. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study. J Psychopharmacol. 2014; 28(8):733-744.

https://doi.org/10.1177/0269881114527362

Unstructured Citation

[31] Bowen S, Chawla N, Marlatt GA. Mindfulness e Comportamenti di Dipendenza. Milano: Raffaello Cortina ed.; 2013.

Unstructured Citation

[32] Shapiro F, Vogelmann-Sine S, Sine LF. Eye movement desensitization and reprocessing: treating trauma and substance abuse. J Psychoactive Drugs 1994; 26(4):379-91.

https://doi.org/10.1080/02791072.1994.10472458

Unstructured Citation

[33] Hase M, Shallmayer S, Sack M, EMDR reprocessing of the Addiction

Unstructured Citation

Memory: pretreatment, Postreatment and 1-month follow up. J EMDR

Unstructured Citation

Practice and research 2008; 2,3:170-179.

Unstructured Citation

[34] Hinnenthal I, Cibin M. Il trattamento residenziale breve delle Dipendenze da

Unstructured Citation

Alcol e Cocaina: il modello Soranzo. Torino: SEED Editore; 2011.

Unstructured Citation

[35] Caputo F, Bernardi M. Medications Acting on the GABA System in the

Unstructured Citation

Treatment of Alcoholic Patients. Curr Pharm Des, 2010; 16: 2118-2125. [36] Chick J, Nutt DJ. Substitution therapy for alcoholism: time for a reappraisal? J Psychopharmacol 2012; 26:205-212.

Unstructured Citation

[37] Keating GM. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in maintenance of abstinence in alcohol dependence. Clin Drug Investig. 2014; 34: 63-80.

https://doi.org/10.1007/s40261-013-0158-x

Unstructured Citation

[38] Quaglio GL, Pattaro C, Gerra G, Mezzelani P, Montanari L, Des Jarlais DC, Lugoboni F. Buprenorphine in maintanance treatment: experience among italian physician in drug addiction centers. Am J Addiction 2010; 10:1-9

Unstructured Citation

[39] Kasliwal R, Wilton LV, Shakir SAW. Safety and drug utilization profile of varenicline as used in general practice in England. Drug Saf 2009; 32:499-507.

https://doi.org/10.2165/00002018-200932060-00006

Unstructured Citation

[41] Lader M. Benzodiazepines revisited--will we ever learn? Addiction 2011; 106: 2086-2109.

https://doi.org/10.1111/j.1360-0443.2011.03563.x

Unstructured Citation

[42] Madrak LN, Rosenberg M. Zolpidem abuse. Am J Psychiatry 2001; 158: 1330-1.

https://doi.org/10.1176/appi.ajp.158.8.1330-a

Unstructured Citation

[43] Faccini M, Leone R, Pajusco B, Quaglio G, Casari R, Albero A, Donati M, Lugoboni F. Lormetazepam Addiction. Data Analysis from an Italian Medical Unit for Addiction. Risk manage Healthcare Pol 2012; 5:43-8.

Unstructured Citation

[44] Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. N. Engl. J. Med. 2015; 372:241-248.

https://doi.org/10.1056/NEJMsa1406143

Unstructured Citation

[45] Weisberg DF, Becker WC, Fiellin DA, Stannard C. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. Int. J. Drug Policy 2014; 25: 1124-1130.

https://doi.org/10.1016/j.drugpo.2014.07.009

Unstructured Citation

[46] Manchikanti L, Helm II S, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV. Opioid epidemic in the United States. Pain Physician 2012; 15: 9-38.

Unstructured Citation

[47] Lugoboni F, Faccini M, Casari R, Guadagnini P, Delaini P. La formazione sulle dipendenze patologiche: possono i SerD avere una funzione didattica vicariante nei confronti dell’Università? Alcune opportunità da non tralasciare. Mission 2013; 37: 55-60.